Bradley Norton joined Gylden in September 2024 as VP of Clinical Operations.

Brad’s background in Clinical Operations goes back more than three decades. He has worked at various levels in Big Pharma companies and CROs (large and small), as well as running his own consulting business for 13 years, where he supported many small biotech companies in a variety of functions: primarily Clinical Operations, but also regulatory support, pharmacovigilance and due diligence. Most recently, Brad was a Senior Clinical Operations Global Program Director at AstraZeneca, where he supported Phase 3 vaccine studies with the AZ COVID vaccine and planned the implementation of two pre-clinical assets into the clinic.